Hantavirus Outbreak Statistics in Canada 2026 | Cases, Timeline & Facts

Hantavirus Outbreak Statistics in Canada 2026 | Cases, Timeline & Facts

What is Hantavirus and Why is Canada Involved in the 2026 Outbreak?

Hantavirus is a family of over 50 types of RNA viruses carried by rodents worldwide, capable of causing two serious human diseases: Hantavirus Pulmonary Syndrome (HPS), the form most prevalent in the Americas, and Haemorrhagic Fever with Renal Syndrome (HFRS), more common in Asia and Europe. In Canada, the rodent host responsible for domestic hantavirus transmission is the deer mouse (Peromyscus maniculatus), which carries the Sin Nombre virus (SNV) — the strain responsible for all 168 confirmed cases of hantavirus infection in Canada since national active surveillance began in 1994. HPS is a severe, often fatal respiratory illness: infection follows inhalation of aerosols from the urine, droppings, or saliva of infected rodents, and the disease progresses rapidly from flu-like symptoms (fever, muscle aches, fatigue) to acute respiratory distress that can kill within days. There is no approved vaccine and no specific antiviral treatment. The average case fatality rate for HPS in North America is approximately 40% — making it one of the most lethal infectious diseases on the continent by case fatality measure. Across Canada’s history of hantavirus surveillance, the National Microbiology Laboratory has confirmed 109 cases and 27 deaths from hantavirus infection since 1989.

The 2026 outbreak that has thrust hantavirus into global headlines and connected Canada directly to an international public health emergency is a fundamentally different kind of event — not a domestic rodent-exposure cluster but an extraordinary, unprecedented outbreak of Andes virus (ANDV) aboard the luxury Dutch polar expedition cruise ship MV Hondius, which departed Ushuaia, Argentina on April 1, 2026 for an Antarctic voyage. ANDV is the only known hantavirus strain capable of person-to-person transmission, and the MV Hondius outbreak marks the first documented ANDV outbreak in a cruise ship setting in history. Canadian passengers were aboard the vessel, and as of May 17, 2026, Canada has recorded its first confirmed case of Andes hantavirus — a Yukon resident self-isolating in Victoria, British Columbia, whose positive result was confirmed by the National Microbiology Laboratory in Winnipeg and announced publicly on May 17, 2026. The situation remains active, rapidly evolving, and is being monitored in real time by the Public Health Agency of Canada (PHAC), provincial health authorities, the World Health Organization (WHO), and public health bodies in over a dozen countries. This article draws exclusively on PHAC official press releases, WHO Disease Outbreak News bulletins, NCCID analysis, CBC News, Globe and Mail, and Wikipedia’s MV Hondius outbreak article — all verified and current as of May 17, 2026.


Key Facts: Hantavirus Outbreak Statistics Canada 2026

The following table captures the most current and verified hantavirus Canada 2026 facts — updated to reflect developments as of May 17, 2026.

Key Fact Verified Stat
Canada’s confirmed Andes hantavirus cases (May 17, 2026) 1 confirmed case — Yukon resident, isolating in Victoria, BC
Confirmation authority National Microbiology Laboratory, Winnipeg — confirmed May 17, 2026
Province of isolation British Columbia (Victoria, Vancouver Island)
Province of residence of confirmed case Yukon
Confirmed case’s travel partner Tested NEGATIVE — confirmed negative by National Microbiology Lab
Date presumptive positive announced Saturday, May 16, 2026 — by Dr. Bonnie Henry, BC Provincial Health Officer
Symptoms onset date (confirmed case) Thursday, May 14, 2026 — mild fever and headache
High-risk contacts in Canada (as of May 14, 2026) 9 high-risk contacts — in BC, Ontario, and Alberta
Low-risk contacts in Canada (as of May 14, 2026) 26 low-risk contacts — contacted by local public health; no isolation required
Total Canadians connected to the outbreak (May 14) 36 total (9 high-risk + 26 low-risk + 1 previously reclassified to low)
Self-isolation period required for Canadian high-risk contacts Minimum 21 days, maximum 42 days — from May 10, 2026 (last day case was aboard)
Date four Canadian passengers returned to Canada May 10, 2026 — arrived in British Columbia
Overall risk to Canadian general public (PHAC, May 17) LOW — onward spread beyond close contacts not expected
Global MV Hondius confirmed cases (as of May 13, WHO DON) 11 cases — 3 deaths (Canadian case brings total to 12 by May 17)
Global MV Hondius confirmed lab cases (as of May 13) 8 confirmed; 3 suspected/inconclusive
MV Hondius departure date and location April 1, 2026 — Ushuaia, Argentina
Index (first) case of MV Hondius outbreak Dutch national, age 70, fell ill April 6; died April 11, 2026
Total deaths in MV Hondius outbreak (global) 3 deaths — Dutch couple + German woman
Countries with confirmed cases or hospitalizations Australia, Canada, France, Germany, Netherlands, South Africa, Spain, Switzerland, UK, + others
Countries with confirmed quarantines 15 countries (Wikipedia, May 15, 2026)
ANDV significance Only hantavirus strain capable of human-to-human transmission
This outbreak’s historical significance First documented ANDV outbreak in a cruise ship setting — ever
Canada’s domestic hantavirus cases since 1994 (surveillance) 168 confirmed cases — all Sin Nombre virus (as of May 1, 2026)
Canada’s domestic hantavirus deaths since 1989 27 deaths from 109 confirmed cases (Health Canada surveillance)
Average global HPS case fatality rate ~40% — North and South America (Health Canada surveillance data)
PHAC overall risk assessment (May 17, 2026) “Overall risk to general population remains low” — onward spread unlikely

Data Sources: Public Health Agency of Canada — “Media Update on Andes Hantavirus Situation” (canada.ca, May 10, 2026); PHAC — “Media Update on Andes Hantavirus Situation” (canada.ca, May 16, 2026 — presumptive positive); PHAC — “Media Update on Andes Hantavirus Situation” (canada.ca, May 17, 2026 — confirmed case); CBC News — “National Lab Confirms Hantavirus Case for Canadian Cruise Passenger Isolating in BC” (May 17, 2026); CBC News — “Canadian Cruise Passenger Isolating in BC Tests Presumptive Positive for Hantavirus” (May 16, 2026)

These 26 data points capture a public health event that is simultaneously a significant international outbreak and a carefully managed, low-risk scenario for the Canadian general public. The single confirmed Canadian case — a Yukon resident in their 70s, part of a couple, developing mild symptoms (fever and headache) on May 14 and testing presumptive positive on May 16 before National Microbiology Lab confirmation on May 17 — is entirely within the anticipated epidemiological trajectory: all 12 confirmed global cases as of May 17 have been passengers or crew aboard the MV Hondius, and no second-generation transmission — infection of someone who was not on the ship — has been documented anywhere in the world. The PHAC’s characterization of overall public risk as “low” is consistent with what ANDV epidemiology would predict: while ANDV is unique among hantaviruses in its human-to-human transmission capacity, that transmission requires close, prolonged contact with a person in the early symptomatic phase of illness — a condition met aboard the ship but not in casual community settings. The 9 high-risk contacts in Canada isolating under active public health monitoring in BC, Ontario, and Alberta, and the 26 low-risk contacts being informed and monitored without isolation requirements, represent a contact tracing response that Canada’s Chief Public Health Officer Dr. Joss Reimer publicly described as consistent with WHO guidance and precautionary in its scope.


MV Hondius Hantavirus Outbreak — Full Timeline 2026

MV Hondius Hantavirus Outbreak — Chronological Timeline

MARCH 20, 2026  Departure from Ushuaia, Argentina (African CDC says April 1 in some reports)
APRIL 1, 2026   Confirmed voyage begins; ship departs for Canary Islands via Cabo Verde
APRIL 6, 2026   Index case (Dutch national, male, 70) falls ill — fever, headache, diarrhea (WHO)
APRIL 11, 2026  Index case dies on board; cause of death undetermined at time; remains on ship
APRIL 24, 2026  Ship stops in Saint Helena (British territory, South Atlantic)
                30 passengers disembark including deceased's wife (Dutch, female)
                6 American passengers disembark; Canadian passengers among those stopping here
APRIL 26, 2026  Wife of index case (Dutch, female) dies in Johannesburg hospital, South Africa
                Her remains and those of her husband eventually repatriated to the Netherlands
APRIL 27, 2026  British passenger evacuated from Ascension Island to South Africa — high fever,
                shortness of breath, signs of pneumonia
MAY 2, 2026     Second on-board fatality — German woman dies on ship after 4 days of illness;
                signs of pneumonia
                British patient in South Africa tests positive for hantavirus — first lab confirmation
                ANDV outbreak officially becomes known internationally
                WHO notified; PHAC issues first rapid risk assessment
                Africa CDC — 7 cases identified: 2 confirmed, 5 suspected; 3 deaths
MAY 4, 2026     Dutch woman's remains in South Africa test positive — second lab confirmation
                Argentina's health ministry reports 101 domestic hantavirus infections since June 2025
                (double prior year caseload; potential exposure origin being investigated)
MAY 6, 2026     Swiss man (passenger, disembarked April 24) confirmed positive — Zurich hospital
                Total cases: 8; 3 hospitalizations; 3 deaths
                3 more evacuated from ship by air ambulance — including ship's doctor (Dutch, 56yo)
MAY 7, 2026     WHO director-general Tedros Adhanom Ghebreyesus briefs media; calls risk "low"
                CDC (US) classifies outbreak as Level 3 emergency response
                5 of 8 suspected cases confirmed hantavirus (ANDV); WHO public risk assessment: LOW
                Passengers from 12 countries had disembarked at Saint Helena (including Canadians)
MAY 8, 2026     WHO DON published — 8 cases: 5 confirmed, 3 suspected; 3 deaths
                British military parachute to Tristan da Cunha from RAF A400M — monitor resident
                ANDV genome sequence published on virological.org ("ANDV/Switzerland/Hu-3337/2026")
MAY 10, 2026    Ship arrives in Tenerife, Canary Islands — Spain approved docking despite Canary
                Islands president's objections
                Passengers disembark; evacuation flights to 6+ European countries and Canada
                FOUR CANADIAN PASSENGERS arrive safely in British Columbia
                Canada begins self-isolation period (minimum 21 days, maximum 42 days)
                Canada confirms: 9 high-risk contacts (BC, Ontario, Alberta)
                Travel ban: any MV Hondius passenger/crew since April 1 prevented from boarding
                flights to Canada
MAY 11, 2026    NCCID confirms: "all Canadians who were aboard the cruise are asymptomatic"
                MV Hondius continues to Netherlands (scheduled to arrive May 18)
MAY 13, 2026    WHO DON update: 11 global cases (2 new: France + Spain); 3 deaths; 8 confirmed
                France case became symptomatic during repatriation flight
                Spain case tests positive on arrival — currently well and asymptomatic
                US case: inconclusive (one positive, one negative); retesting underway
MAY 14, 2026    26 low-risk contacts in Canada identified — had shared flights with confirmed cases
                (flew from St. Helena and other points)
                Canada total connected: 36 (9 high-risk + 26 low-risk + 1 reclassified to low)
                Dr. Joss Reimer (Chief Public Health Officer of Canada) news conference
MAY 16, 2026    DR. BONNIE HENRY (BC Provincial Health Officer) announces presumptive positive
                Yukon resident (couple in 70s, isolating in Victoria): developed fever + headache May 14
                Both transferred to hospital in Victoria; tested presumptive positive by BC lab
                Third BC isolating passenger transferred to hospital "out of abundance of caution"
                Fourth continues isolating at home
MAY 17, 2026    NATIONAL MICROBIOLOGY LABORATORY (Winnipeg) CONFIRMS:
                One Yukon resident — POSITIVE for Andes hantavirus
                Travel partner — confirmed NEGATIVE
                Canada's first confirmed case of ANDV
                Global total: 12 cases; 3 deaths; all cases were passengers or crew aboard MV Hondius
Date Event Key Figure / Number
April 1, 2026 MV Hondius departs Ushuaia, Argentina 147 passengers + crew; 23 nationalities
April 6 Index case falls ill on board Dutch national, male, 70; fever, headache, diarrhea
April 11 Index case dies on board First death; cause undetermined at time
April 24 Ship stops in Saint Helena 30 passengers disembark; Canadians among them
April 26 Index case’s wife dies in Johannesburg Second death; later confirmed ANDV
May 2 Third death (German woman) on board Ship in Cape Verde waters; first positive lab test
May 4 Two deaths confirmed ANDV-positive British patient + Dutch woman’s remains test positive
May 6 Swiss man confirmed positive; 3 evacuated Total 8 cases; ship still off Cape Verde
May 7 WHO briefs media; CDC Level 3; risk: LOW 8 cases; 3 deaths; 5 confirmed ANDV
May 8 WHO DON published; genome sequenced “ANDV/Switzerland/Hu-3337/2026” on virological.org
May 10 Ship arrives Tenerife; 4 Canadians return to BC Canada: 9 high-risk contacts; 42-day monitoring begins
May 13 WHO DON update: 11 global cases France + Spain confirmed; US inconclusive
May 14 26 low-risk Canadians identified Flight exposures; Canada total: 36 connected
May 16 Presumptive positive announced (BC) Yukon resident; couple in 70s; mild symptoms
May 17 National Microbiology Lab confirms Canada’s 1st confirmed ANDV case; partner negative

Data Sources: Wikipedia — MV Hondius hantavirus outbreak (updated May 17, 2026); WHO — Disease Outbreak News DON601 (May 13, 2026); WHO — Media briefing by Director-General Tedros (May 7, 2026); PHAC — Media Updates (May 10, May 16, May 17, 2026, canada.ca); Africa CDC — Statement on Multi-Country Hantavirus Cluster (May 4, 2026); CBC News — Timeline of MV Hondius outbreak (May 7, 2026, updated May 11); CBC News — May 16, 2026; Globe and Mail — May 16, 2026; NCCID — Hantavirus Debrief (nccid.ca, updated May 11, 2026)

The MV Hondius timeline is a masterclass in how quickly a contained, geographically remote outbreak can propagate across multiple continents when it occurs in a highly mobile international travel setting. The 47-day span from the index case’s illness onset (April 6) to Canada’s first confirmed ANDV case (May 17) encompasses the full arc of an outbreak that began silently in the South Atlantic — in a region so remote that the nearest adequate medical facility was in South Africa — and ended with confirmed or suspected cases in more than a dozen countries across four continents. The key inflection point in the entire timeline is May 2, 2026: the day the British passenger’s positive test result from South Africa arrived, triggering international awareness 21 days after the index case had died. Those 21 days of undetected transmission — during which passengers continued to interact, the ship visited Saint Helena, and 30 people disembarked and scattered to their home countries — established the geographic distribution of exposure that public health authorities in Canada, the UK, Switzerland, France, Spain, the United States, and elsewhere are now managing through contact tracing, isolation protocols, and active monitoring.

The speed of Canada’s response once the situation became known is notable. From the WHO notification on May 2 through the first PHAC rapid risk assessment, to the managed repatriation of four Canadian passengers directly to dedicated isolation accommodations in British Columbia on May 10, to the public press conferences by Dr. Joss Reimer and Dr. Bonnie Henry that provided daily transparency to Canadians, the response has been characterized by active communication, precautionary action beyond minimum WHO requirements, and genuine coordination between federal and provincial public health bodies. The requirement of minimum 21 days, maximum 42 days of self-isolation — a range that spans the full biological uncertainty of ANDV’s documented incubation period — reflects the application of the precautionary principle that PHAC’s own Rapid Risk Assessment document explicitly recommended.


Canada’s Hantavirus Contacts, Isolation, and Risk Assessment 2026

Canada's Hantavirus Contact Classification Structure — May 14–17, 2026

HIGH-RISK CONTACTS (9 total — as of May 14, 2026):
  ● 4 Canadian passengers who returned to BC May 10, 2026
    → Couple in 70s from Yukon ← ONE NOW CONFIRMED POSITIVE (May 17)
    → Person in 70s from Vancouver Island
    → Person in 50s from BC (currently lives abroad)
  ● 2 individuals who disembarked at an earlier stop (Saint Helena)
  ● 3 individuals potentially exposed on a flight with a confirmed case
  Required action: SELF-ISOLATION (minimum 21 days / maximum 42 days)
  Locations: BC, Ontario, Alberta

LOW-RISK CONTACTS (26 total — as of May 14, 2026):
  ● 26 people who shared flights with a confirmed hantavirus case
    → Flew from St. Helena and connecting routes
    → Seated away from confirmed case; no direct prolonged contact
  Required action: Monitor symptoms; contact local public health
  Required action: NOT required to self-isolate (federal level)
  Note: Local public health units can apply additional direction

TOTAL CANADIANS CONNECTED: 36
  Previously: 37 (one reclassified from high-risk to low-risk after reassessment)
Contact Category Number in Canada Location(s) Required Action
Confirmed ANDV case 1 — Yukon resident, isolating in Victoria, BC British Columbia Hospitalized; negative pressure room; confirmed May 17
Presumptive positive (pending) 0 — partner of confirmed case now confirmed NEGATIVE BC Confirmed negative May 17
High-risk contacts — total 9 BC, Ontario, Alberta Self-isolate 21–42 days; active daily monitoring
High-risk: MV Hondius passengers in BC 4 (includes confirmed case) Vancouver Island / Victoria Hospital or isolation accommodation
High-risk: Saint Helena disembarkers 2 Not specified Self-isolation
High-risk: flight-exposed close contacts 3 Not specified Self-isolation
Low-risk contacts 26 Multiple provinces Monitor symptoms; no mandatory isolation
Previously reclassified to low-risk 1 (Quebec resident) Quebec Reclassified; no longer high-risk
Grand total connected to outbreak 36 Canadians BC, Ontario, Alberta + others Various protocols
Self-isolation period Minimum 21 days; maximum 42 days From May 10, 2026 Began when last confirmed case was aboard
Monitoring duration for all “At least 42 days” active daily monitoring As per Dr. Bonnie Henry Applies to BC 4 in particular
Accommodation Dedicated accommodations — not home quarantine Vancouver Island (Island Health) Hotel/facility isolation
Hospital transfers 3 of 4 BC passengers transferred to hospital Victoria, BC Negative pressure rooms
Home isolating 1 of 4 BC passengers Vancouver Island Remains home; no symptoms (as of May 16)
Flight ban MV Hondius passengers/crew since April 1 — cannot board flight to Canada Federal Transport Canada + air carrier coordination

Data Sources: PHAC — “Media Update on Andes Hantavirus Situation” (canada.ca, May 10 and May 16, 2026); CBC News — “26 More Canadians Being Contacted for Low-Risk Hantavirus Exposure” (May 14, 2026); CTV News — “Canada Informed of 26 Low-Risk Hantavirus Contacts” (May 14, 2026); CBC News — “Canadian Cruise Passenger Isolating in BC Tests Presumptive Positive” (May 16, 2026); Globe and Mail — May 16, 2026; CBC News — “National Lab Confirms Hantavirus Case” (May 17, 2026); Times Colonist (Victoria) — “Canadian Isolating on Vancouver Island Tests Presumptive Positive” (May 16, 2026)

The contact classification and management framework deployed by Canada for the 2026 ANDV outbreak is the most granular and publicly communicated disease contact response Canada has undertaken since the COVID-19 pandemic — and the two situations are, as Dr. Bonnie Henry explicitly stated in her May 16 news conference, fundamentally different in nature. Henry’s words: “I want to emphasize that hantavirus is a very different virus than the other respiratory viruses that we’ve been dealing with — like COVID, like influenza, like measles — and it remains one that we do not consider to have pandemic potential.” The distinction is important and grounded in epidemiology: ANDV, while uniquely capable of human-to-human transmission among hantaviruses, requires close, sustained, prolonged contact with an acutely ill person — the transmission dynamics observed in close domestic settings in South America where ANDV is endemic, not the casual proximity involved in public transportation or shared public spaces. The three previous-documented ANDV outbreaks in South America have all been limited to close family clusters, healthcare workers without proper PPE, and sexual partners — not to community spread. The WHO’s assessment that “the risk of an epidemic is low” and PHAC’s concurrent assessment that “significant onward spread within Canada is not expected” are both based on this well-established ANDV transmission biology.

The practical consequence for the 26 low-risk contacts — who shared flights with a confirmed case but were not seated in proximity for extended periods — is that they are not required to isolate under federal guidance, though local public health units retain discretion to apply additional direction. Dr. Reimer’s May 14 news conference confirmed that these 26 people were being contacted as a precautionary measure — informed of their exposure, told what symptoms to watch for, and placed into the monitoring system for the at-risk period — not because their exposure posed a meaningful individual risk but because the PHAC’s Rapid Risk Assessment recommended applying the precautionary principle throughout the incubation period window. For the 9 high-risk contacts, including the now-confirmed Canadian case, the 21-to-42-day isolation protocol reflects the maximum documented ANDV incubation period and ensures that anyone who was exposed at any point during the ship’s outbreak window has sufficient time in monitored isolation to either develop and receive care for symptoms or be cleared.


Canada’s Domestic Hantavirus History and Endemic Risk Context 2026

Canada's Domestic Hantavirus (Sin Nombre Virus) Surveillance — 1989–2026
(Health Canada; National Microbiology Laboratory; NCCID; canada.ca — updated May 1, 2026)

Since 1989: 109 confirmed cases, 27 deaths (Sin Nombre virus — SNV)
Since 1994 (active surveillance): 168 confirmed cases total (SNV, as of May 1, 2026)
Carrier rodent: Deer mouse (Peromyscus maniculatus)
Transmission: Inhalation of aerosols from infected rodent droppings/urine/saliva
Average HPS case fatality rate: ~40%

Provincial historical case breakdown (up to 2019 NCCID data):
  Saskatchewan:   35 cases — most of any province (up to 2019)
  British Columbia: 19 cases (up to 2019)
  Alberta:         16 cases (2014–2018), 1 fatal; others from earlier periods
  Manitoba:         6 cases (up to 2019; 5 from western travel/military)
  Ontario:          0 confirmed HPS cases ever reported (as of 2019)

High-risk occupations:
  Trappers, hunters, forestry workers, farmers, military personnel
  Males aged 20–40: highest exposure category

KEY DISTINCTION — 2026 outbreak vs domestic hantavirus:
  Domestic SNV: spread by deer mouse inhalation ONLY — no person-to-person
  MV Hondius ANDV: person-to-person transmission possible (close, prolonged contact)
  These are TWO DIFFERENT viruses with different epidemiology
Domestic Hantavirus Metric Figure Source
Confirmed hantavirus cases in Canada since 1994 (NML) 168 cases (as of May 1, 2026) Health Canada — Risks of a Hantavirus Infection (canada.ca)
Confirmed hantavirus cases since 1989 (broader) 109 confirmed Health Canada — Surveillance page (canada.ca)
Deaths from hantavirus since 1989 27 deaths Health Canada — Surveillance page
Average HPS case fatality rate ~40% — North and South America Health Canada surveillance data
Annual HPS cases in North + South America ~200 per year Health Canada surveillance
Global annual HFRS cases (Asia, Europe) 150,000–200,000 Health Canada / NCCID
Canada’s carrier rodent Deer mouse (Peromyscus maniculatus) Health Canada
Canada’s endemic strain Sin Nombre virus (SNV) Health Canada
Saskatchewan — highest provincial case count 35 cases (up to 2019) NCCID Hantavirus Debrief
British Columbia cases (up to 2019) 19 cases NCCID
Alberta cases (2014–2018) 16 cases; 1 fatal NCCID
Manitoba cases (up to 2019) 6 cases (5 from western provinces exposure) NCCID
Ontario — confirmed HPS cases ZERO — no confirmed cases ever NCCID
Highest-risk group Males aged 20–40; rural occupations NCCID; Health Canada
Person-to-person transmission of SNV NOT possible — inhalation from rodents only Health Canada
Person-to-person transmission of ANDV (2026 outbreak virus) POSSIBLE — close, prolonged contact WHO; PHAC
ANDV endemicity in Canada NOT endemic — imported from MV Hondius PHAC Rapid Risk Assessment

Data Sources: Health Canada — “Risks of a Hantavirus Infection” (canada.ca, updated May 1, 2026 — confirming 168 cases); Health Canada — “Surveillance of Hantavirus Related Diseases” (canada.ca — 109 cases, 27 deaths since 1989); NCCID — “Hantavirus Debrief” (nccid.ca, updated May 2026 — provincial breakdown); PHAC — Rapid Risk Assessment: Hantavirus (ANDV) Outbreak on International Cruise Ship (canada.ca)

Understanding the 2026 ANDV outbreak in the context of Canada’s domestic hantavirus history requires holding two entirely separate epidemiological frameworks simultaneously — because these are, in the most literal virologcal sense, two different diseases caused by two different viruses with different host animals, different transmission mechanisms, and different geographic origins. Canada’s domestic hantavirus burden — the 168 confirmed cases since 1994, spread overwhelmingly across rural Western Canada where deer mouse populations are densest, concentrated in Saskatchewan (35 cases), BC (19), and Alberta (16), and killing approximately 40% of those infected — exists as a persistent, low-level endemic public health concern that has never triggered the kind of national media attention the MV Hondius outbreak has generated. The primary reason is precisely the zero person-to-person transmission capacity of Sin Nombre virus: a Canadian farm worker who contracts HPS from cleaning a barn where deer mice have nested is in serious personal danger, but poses no risk to family members, healthcare workers, or community contacts. The management of domestic HPS cases is entirely clinical, not contact-tracing-based.

The ANDV situation is categorically different — the specific reason why PHAC issued a Rapid Risk Assessment, why Dr. Joss Reimer held multiple news conferences, why Transport Canada coordinated with airlines to prevent MV Hondius passengers from boarding Canada-bound flights, and why four Canadians are being monitored in dedicated isolation accommodations rather than simply at home. ANDV’s human-to-human transmission capacity — which has been documented in several South American outbreaks since the 1990s, particularly in Chile and Argentina where the virus is endemic — means that an infected person arriving in Canada is not merely a clinical patient but a potential transmission source for close contacts. The PHAC Rapid Risk Assessment’s designation that the likelihood of ANDV importation into Canada was “moderate” (as of May 11, before the confirmed case on May 17) reflected precisely this distinction: moderate likelihood of a case arriving, but low likelihood of onward community transmission given ANDV’s specific transmission requirements. The confirmed May 17 case — a Yukon resident who has been in dedicated isolation since May 10, being cared for in a negative-pressure hospital room in Victoria — is, thus far, the precise scenario that public health protocols were designed to contain.


Global Hantavirus Context and ANDV Outbreak Statistics 2026

MV Hondius ANDV Outbreak — Global Case Summary (as of May 17, 2026)

CONFIRMED CASES (lab-confirmed ANDV): 8+ (11–12 total including suspected)
DEATHS: 3 — Dutch male (April 11), Dutch female (April 26), German female (May 2)
HOSPITALIZATIONS: 3+ — South Africa (British national, ICU); Netherlands; others

Countries with confirmed cases or quarantined passengers (as of May 15):
  Australia, Canada, France, Germany, Netherlands, Saint Helena,
  Singapore, South Africa, Spain, Switzerland, Turkey, United Kingdom,
  United States (inconclusive), + others

Case fatality rate — MV Hondius outbreak: 3 deaths / 11–12 cases = ~25–27%
  (Within range of historical ANDV outbreaks: 25–35% CFR)

For comparison — Canada's endemic SNV (domestic):
  Average CFR: ~40%
  Total deaths since 1989: 27

Global HFRS (Asia/Europe, other hantavirus strains):
  150,000–200,000 cases per year globally
  CFR: <1% to 12% depending on strain
  China: highest global burden
Global Metric Figure (as of May 17, 2026) Source
Total MV Hondius cases globally 12 (11 per WHO May 13 + Canada confirmed May 17) WHO DON; PHAC May 17
Lab-confirmed cases 8 confirmed (as of WHO May 13); Canadian case = 9th WHO DON May 13, 2026
Suspected/inconclusive cases 3 suspected + 1 US inconclusive (as of May 13) WHO DON May 13
Total deaths globally 3 deaths — Dutch male, Dutch female, German female WHO; Africa CDC; CBC News
MV Hondius outbreak case fatality rate ~25–27% (3 of 11–12 cases) Calculated from WHO data
Historical ANDV outbreak CFR 25–35% — South American outbreaks Published literature
Passengers aboard MV Hondius 147 individuals including crew; 23 nationalities Wikipedia
Nationalities of passengers (majority) Spain, France, UK, US — bulk of passengers Wikipedia
Crew origin (majority) Philippines Wikipedia
Berth price (cruise fare range) €14,000 to €22,000 Wikipedia
WHO risk assessment “Overall public health risk is low” — Dr. Tedros May 7 WHO
CDC (US) response level Level 3 emergency response CDC (cited Wikipedia)
WHO diagnostic kits shipped 2,500 diagnostic kits from Argentina — to labs in 5 countries WHO response statement
WHO expert deployed On board MV Hondius — medical assessment of all passengers/crew WHO
Ship’s final destination Netherlands — scheduled arrival May 18, 2026 Wikipedia
First-ever ANDV cruise ship outbreak YES — historically unprecedented WHO; PHAC Rapid Risk Assessment
Argentina domestic hantavirus 2025–26 101 cases since June 2025 — double prior year rate Associated Press (cited Time, May 2026)
HPS cases per year (North + South America) ~200 annually Health Canada
Global HFRS cases per year 150,000–200,000 — primarily China Health Canada

Data Sources: WHO — “Disease Outbreak News: Hantavirus Cluster Linked to Cruise Ship Travel, Multi-Country” (DON601, May 13, 2026); WHO — “Response to Hantavirus Cases Linked to a Cruise Ship” (Media statement by DG Tedros, May 7, 2026); Wikipedia — MV Hondius hantavirus outbreak (updated May 17, 2026); Africa CDC — Statement on Multi-Country Hantavirus Cluster (May 4, 2026); Time — “What Countries Are Linked to the Hantavirus Outbreak?” (May 7, 2026); PHAC — Rapid Risk Assessment: ANDV Outbreak on International Cruise Ship (canada.ca); Health Canada — Surveillance of Hantavirus Related Diseases (canada.ca)

The global scale of the MV Hondius ANDV outbreak — 12 confirmed cases, 3 deaths, and quarantined or monitored individuals in at least 15 countries across four continents by May 2026 — represents one of the most geographically distributed hantavirus events in medical history. This distribution is not the result of viral spread between countries but of the demographics of polar expedition cruising: the passengers and crew of the MV Hondius, who paid between €14,000 and €22,000 per berth, came from 23 nationalities, and when the outbreak became known internationally, they were scattered across those 23 home countries with varying degrees of exposure, incubation, and symptom status. The ship’s unique routing — from Ushuaia, Argentina (in the Southern Cone, where ANDV is endemic in rodent populations) through the remote South Atlantic before heading north to Cape Verde and ultimately the Canary Islands — provided both the plausible exposure source (contact with ANDV-infected rodents in or around Ushuaia, potentially at a landfill during a bird-watching outing as investigators have suggested) and the logistical complexity: the ship was three days anchored off Cape Verde, which declared itself unable to manage the medical emergency, before Spain’s approval allowed it to dock in Tenerife on May 10.

The WHO’s deployment of a medical expert directly aboard the MV Hondius, the shipment of 2,500 diagnostic kits from Argentina to laboratories in five countries, and the activation of International Health Regulations (IHR) channels for inter-country information sharing represent the most comprehensive WHO response to a hantavirus outbreak in the organization’s history — reflecting both the genuine severity of the event and the unprecedented challenge of managing a human-to-human transmissible respiratory virus aboard a ship in the middle of the South Atlantic. The Argentina domestic context adds an important layer: the Associated Press reported that Argentina’s health ministry had confirmed 101 hantavirus infections since June 2025 — approximately double the caseload of the equivalent prior-year period — suggesting elevated ANDV circulation in the Ushuaia region where the ship departed, and providing a plausible epidemiological explanation for how two Dutch tourists may have contracted the virus during shore excursions before returning to the ship.

Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.

📩Subscribe to Our Newsletter

Get must-read Data Reports, Global Insights, and Trend Analysis — delivered directly to your inbox.